New York Attorney General Cuomo Statement Regarding Inefficacy Of Heart Disease Drug Vytorin
April 2, 2008 -- "The full results of the study released today, showing that Vytorin had no effect on heart disease, put the lie to Merck and Schering-Plough’s $200 million advertising campaign urging Americans to take this drug.
While these corporations profited, Americans were left in the dark. The millions who take this drug, taxpayers who subsidize its use through the Medicaid and Medicare programs, and Merck and Schering-Plough’s investors deserve to know why it took so long for the results to be made public.
This new information underscores our concerns and advances our investigation, which we will pursue aggressively."
Source: New York Attorney General
Similar
- Washington Attorney General announces settlements with Merck
- Merck Pays Utah $2.25 Million In Medicaid Rebate Settlement
- Pennsylvania Attorney General Corbett announces $8.5 million PA drug pricing settlement with Merck & Co.
- New Jersey to Receive More Than $7 Million in Medicaid Settlement With Merck & Co.
- Nevada AG Masto Announces $400 Million Nationwide Settlement With Merck
Latest stories
- Iowans Should Take a Holiday from Disaster-Related Stress This Weekend
- EPA Is Not Currently Performing Indoor Air Sampling in Response to Iowa Floods
- EPA Monitors Air Quality in Cleanup from Iowa Floods
- Be Vigilant for Disaster Scam Artists
- Pfizer Announce Changes to Its Funding of Continuing Medical Education in the U.S.
- IBM Acquires Platform Solutions Technology Company
- CoverGirl, P.F. Chang's China Bistro Team up in Celebration of the Essence Music Festival
- AT&T, Cell Phones for Soldiers Surpass First-Year Goal
- Wal-Mart Commits to America's Farmers as Store Produce Aisles Go Local
- IBM, ETH Scientists Advance Supercomputing Simulations to Improve Diagnosis of Osteoporosis
Yes We Can
Yes We Can:

















